Veracyte Inc’s recently made public that its Chief Commercial Officer-CLIA Leite John unloaded Company’s shares for reported $0.23 million on Mar 07 ’25. In the deal valued at $31.66 per share,7,411 shares were sold. As a result of this transaction, Leite John now holds 100,249 shares worth roughly $2.91 million.
Then, JOHN LEITE bought 7,411 shares, generating $240,932 in total proceeds.
Before that, ANN MCGUIRE bought 1,142 shares. Veracyte Inc shares valued at $38,326 were divested by the Officer at a price of $33.56 per share.
Craig Hallum initiated its Veracyte Inc [VCYT] rating to a Buy in a research note published on March 20, 2025; the price target was $45. A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in early December from “a Buy” to “a Neutral”. Wolfe Research began covering VCYT with “an Outperform” recommendation on November 15, 2024. UBS started covering the stock on October 16, 2024. It rated VCYT as “a Buy”.
Price Performance Review of VCYT
On Monday, Veracyte Inc [NASDAQ:VCYT] saw its stock fall -0.68% to $29.00. Over the last five days, the stock has lost -5.72%. Veracyte Inc shares have fallen nearly -26.77% since the year began. Nevertheless, the stocks have risen 23.14% over the past one year.
How much short interest is there in Veracyte Inc?
A steep rise in short interest was recorded in Veracyte Inc stocks on 2025-04-30, growing by 1.4 million shares to a total of 5.57 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 4.17 million shares. There was a rise of 25.17%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 10, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $40 price target.
